Arrowhead Research | Spese Operative



Operating Expenses Cambiamento Data
Agios Pharmaceuticals USD 135.77M 1.11B 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Arrowhead Research USD 163.91M 1.71M 2024-12
Incyte USD 877.18M 114.6M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
Ligand Pharmaceuticals USD 52.45M 3.78M 2024-12
Merck USD 11.33B 1.4B 2024-12
Moderna USD 2.21B 280M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Xencor USD 65.97M 7.02M 2024-12



Arrowhead Research Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.